← Back to all substances
J

ciprofloxacin

225ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

INDICATIONS AND USAGE Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epider...

Known as: ciprofloxacin
Route: OPHTHALMIC
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
83,672
Total in FDA
90%
Serious Reports
62
Fatal Outcomes

Seriousness

Serious
451
Non-Serious
49

Sex Distribution

Male
196
Female
264
Unknown
40

Age Distribution

0-17
15
18-40
83
41-64
147
65-84
150
85+
22
Unknown
83

Outcomes

Recovered/Resolved
343
Recovering/Resolving
112
Not Recovered/Not Resolved
315
Recovered with Sequelae
9
Fatal
62
Unknown
1044

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-01bf79
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...